基于融合多期MRI的肝细胞癌分割与组织学分级一体化多任务学习框架
本研究回顾性分析1673例经组织病理学确诊的肝细胞癌患者(875例高级别、798例低级别)的MRI数据,采用动脉期与门静脉期T1加权图像,比较六种分割模型在动脉期、门静脉期及小波融合图像上的表现,并从分割肿瘤体积中提取215个影像组学特征进行分级。Transformer-RFE-Fused模型表现最优,训练准确率93.2%、测试准确率92.5%,融合模态AUC超过96%,分割DSC均高于0.92。
要点
- 融合多期MRI的多任务框架可同时完成肝细胞癌分割与组织学分级,融合模态分割DSC均高于0.92。
- Transformer-RFE-Fused模型分级表现最优,训练准确率93.2%、测试准确率92.5%,融合模态AUC超过96%。
- SHAP分析证实关键影像组学特征贡献度高,t-SNE可视化显示低级别与高级别肿瘤分离清晰。
核心结论
- 一体化多任务学习框架明显提升了肝细胞癌肿瘤分割与分级的表现。
- Transformer-RFE-Fused(小波)MRI具有更高的准确性与稳健性,为增强临床决策铺路。
研究设计与样本
- 回顾性研究,纳入1673例经组织病理学确诊的肝细胞癌患者,其中高级别875例、低级别798例。
- 采用标准化团注追踪方案采集动脉期与门静脉期T1加权图像,以确保对比剂 timing 一致。
- 在动脉期、门静脉期及基于小波的融合MRI数据上训练Vision Transformer、nnU-Net、U-Net、DeepLabV3+、Swin Transformer与SegNet六种分割模型。
- 从分割肿瘤体积中提取215个影像组学特征,采用Lasso、递归特征消除(RFE)与ANOVA进行特征筛选。
- 采用TabTransformer、TabNet、XGBoost与CatBoost进行肿瘤分级分类,使用五折交叉验证与独立测试集评估。
关键影像表现/征象
- 融合MRI图像上分割DSC均高于0.92。
- 训练准确率达93.2%,测试准确率92.5%,融合模态AUC值超过96%。
- Transformer-RFE-Fused模型优于其他架构,表现出更优的泛化能力与稳健的特征学习。
- SHAP分析证实关键影像组学特征贡献度高,t-SNE可视化显示低级别与高级别肿瘤之间分离清晰。
诊断标准与关键数值
- 分割准确度以DSC评估,融合MRI图像上DSC均高于0.92。
- 分级分类性能:训练准确率93.2%,测试准确率92.5%,融合模态AUC值超过96%。
- 影像组学特征共215个,经预过滤去除多重共线性后以Lasso、RFE与ANOVA筛选。
临床应用与阅片要点
- 本框架将深度学习分割与影像组学分级整合,可在融合多期MRI上同时输出肿瘤分割与组织学分级结果。
- Transformer-RFE-Fused(小波)MRI在分割与分级上均表现最优,融合模态AUC超过96%。
- SHAP与t-SNE分析分别支持关键影像组学特征的高贡献度及低级别与高级别肿瘤的清晰分离。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: This study aims to develop and validate an integrated multi-task framework for hepatocellular carcinoma analysis by combining deep learning-based segmentation with radiomics-based histological grading using fused multi-phase MRI.
MATERIALS AND METHODS: In this retrospective study, MRI data from 1673 patients with histopathologically confirmed hepatocellular carcinoma (875 high-grade, 798 low-grade) were analyzed. Arterial-phase and portal-venous-phase T1-weighted images were acquired using a standardized, bolus-tracking protocol to ensure consistent contrast timing. Six segmentation models, Vision Transformer, nnU-Net, U-Net, DeepLabV3+, Swin Transformer, and SegNet, were trained on arterial, portal-venous, and fused (wavelet-based) MRI data. Radiomic features (n = 215) were extracted from segmented tumor volumes and pre-filtered to remove multicollinearity. Feature refinement was performed using Lasso, Recursive Feature Elimination (RFE), and ANOVA. Tumor grade classification was conducted using TabTransformer, TabNet, XGBoost, and CatBoost. Five-fold cross-validation and an independent test set were used for robust evaluation. Standardized preprocessing, including intensity normalization, bias field correction, and inter-phase registration, ensured consistent image quality and analytical reproducibility.
RESULTS: The proposed framework achieved high segmentation accuracy with DSC scores above 0.92 across fused MRI images. Classification performance was exceptional, with training accuracy reaching 93.2% and testing accuracy 92.5%, while AUC values exceeded 96% in the fused modality. Comparative analyses revealed that the Transformer-RFE-Fused model outperformed alternative architectures, demonstrating superior generalization and robust feature learning. In addition, SHAP analysis confirmed the high contribution of key radiomic features, and t-SNE visualizations illustrated clear separation between low-grade and high-grade tumors. These results validate the efficacy of our multi-task learning approach in enhancing HCC tumor segmentation and grading. Our evaluation underscores the clinical potential of our integrated framework for accurate, reproducible, and interpretable HCC diagnosis.
CONCLUSIONS: Our integrated multi-task learning framework markedly improves HCC tumor segmentation and grading. Transformer-RFE-Fused (Wavelet) MRI offers superior accuracy and robustness, efficiently paving the way for enhanced clinical decision-making.
引用
- You Z, Wang Y, Zhou S, et al. Integrated multi-task learning framework for hepatocellular carcinoma segmentation and histological grading using fused multi-phase MRI. Abdom Radiol (NY). 2025. PMID: 41160193. doi:10.1007/s00261-025-05266-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。